@naturgemalde.bsky.social
Reposted
Why are manufacturers not meeting European payer evidence requirements in HTA evaluations? Our Market Access & Commercialization team shares their insights.
🔴🧠
#HTA #EuropeanHTA #pharma
rednucleus.com/resources/ht...
🔴🧠
#HTA #EuropeanHTA #pharma
rednucleus.com/resources/ht...
Navigating HTA Challenges in EU Markets
Strategies to Overcome Data Hurdles for P&MA Success
rednucleus.com
March 26, 2024 at 5:07 PM
Why are manufacturers not meeting European payer evidence requirements in HTA evaluations? Our Market Access & Commercialization team shares their insights.
🔴🧠
#HTA #EuropeanHTA #pharma
rednucleus.com/resources/ht...
🔴🧠
#HTA #EuropeanHTA #pharma
rednucleus.com/resources/ht...
Reposted
Meet our team at the 41st Annual Miami Breast Cancer Conference this week, and learn more about the future of Medical Communications and Learning & Development.
Not in Miami? Reach out to us at the link below. #oncology #medcomms #LearningAndDevelopment rednucleus.com/contact-us
Not in Miami? Reach out to us at the link below. #oncology #medcomms #LearningAndDevelopment rednucleus.com/contact-us
March 7, 2024 at 3:24 PM
Meet our team at the 41st Annual Miami Breast Cancer Conference this week, and learn more about the future of Medical Communications and Learning & Development.
Not in Miami? Reach out to us at the link below. #oncology #medcomms #LearningAndDevelopment rednucleus.com/contact-us
Not in Miami? Reach out to us at the link below. #oncology #medcomms #LearningAndDevelopment rednucleus.com/contact-us